Proposal to assess an innovative Immunotherapy, based on a thioredox peptide antigen, in a Phase I Trial for Type-1 Diabetes

Project Information

EXALT

Grant agreement ID: 602515

Closed project

Start date 1 February 2014

End date 31 January 2019

Funded under

• Specific Programme "Cooperation": Health

Total cost € 13 076 048,57

EU contribution € 6 000 000,00

Coordinated by

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
France